177 related articles for article (PubMed ID: 30737252)
1. Ti
Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
[TBL] [Abstract][Full Text] [Related]
4. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
Phiboonchaiyanan PP; Chanvorachote P
Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
[TBL] [Abstract][Full Text] [Related]
5. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
[TBL] [Abstract][Full Text] [Related]
6. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
Petpiroon N; Sritularak B; Chanvorachote P
BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
[TBL] [Abstract][Full Text] [Related]
7. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
[TBL] [Abstract][Full Text] [Related]
8. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
Luo W; Liu Q; Jiang N; Li M; Shi L
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
[TBL] [Abstract][Full Text] [Related]
12. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
[TBL] [Abstract][Full Text] [Related]
13. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
[TBL] [Abstract][Full Text] [Related]
16. Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration.
Khan P; Bhattacharya A; Sengupta D; Banerjee S; Adhikary A; Das T
Sci Rep; 2019 Nov; 9(1):16913. PubMed ID: 31729456
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway.
Srinual S; Chanvorachote P; Pongrakhananon V
Int J Oncol; 2017 Apr; 50(4):1341-1351. PubMed ID: 28259926
[TBL] [Abstract][Full Text] [Related]
18. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis.
Chantarawong W; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30754694
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
[TBL] [Abstract][Full Text] [Related]
20. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
